C4 Therapeutics Inc Cash Flow Reinvestment Rate
C4 Therapeutics Inc cash flow reinvestment rate. C4 Therapeutics Inc (CCCC) has a Cash Flow Reinvestment Rate of 0.02x as of June 2019, reinvesting $641.00K (capex $641.00K ) from operating cash flow of $36.91 Million. Explore CCCC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of C4 Therapeutics Inc (2019–2019)
Cash flow reinvestment rate of C4 Therapeutics Inc from 2019 to 2019. Historical reinvestment intensity for C4 Therapeutics Inc across 1 annual periods. Explore CCCC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
C4 Therapeutics Inc Cash Flow Reinvestment Rate by Year (2019–2019)
C4 Therapeutics Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for C4 Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does C4 Therapeutics Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.05x | $2.97 Million | $55.61 Million | $1.35 Million | — |